文献速递免疫规划传染病防控与疫情报告

严重神经系统疾病患儿接种含麻疹疫苗的效果

Effects of measles-containing vaccination in children with severe underlying neurologic disease.
PubMed 文献 · Vaccine · 2020-12-03

结果显示51.8%家长报告无不良事件,不良事件包括无热惊厥(6/36)、单纯发热(5/36)和热性惊厥(5/36),2名患儿需住院。四价含麻疹疫苗联合水痘疫苗与热性惊厥相关(p=0.04)。

要点

  • 严重神经系统疾病患儿接种含麻疹疫苗总体可耐受,半数以上无不良事件。
  • 主要副作用为已知癫痫患儿的惊厥加重,但无需调整抗癫痫治疗。
  • 四价含麻疹疫苗联合水痘疫苗与热性惊厥相关(p=0.04)。

核心结论

  • 在严重神经系统疾病患儿中,含麻疹疫苗成分的疫苗安全性-耐受性特征支持接种的合理性。

研究设计与样本

  • 在麻疹暴发期间,为未接种的严重神经系统疾病患儿提供含麻疹疫苗,接种后30天由家长报告不良事件,接种后12个月评估长期影响。

主要发现

  • 51.8%的家长报告无免疫接种后不良事件。
  • 不良事件包括无热惊厥(6/36)、单纯发热(5/36)和热性惊厥(5/36)。
  • 2名儿童需要住院。
  • 四价含麻疹疫苗联合水痘疫苗与热性惊厥相关(p=0.04)。
  • 没有儿童需要调整抗癫痫治疗或表现出发育倒退。

临床怎么用

  • 对于严重神经系统疾病患儿,在麻疹暴发期间可考虑接种含麻疹疫苗,但需关注惊厥加重风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Measles outbreaks pose significant risk for those unvaccinated. PATIENTS AND METHODS: Measles-containing vaccine was offered to unvaccinated children with severe neurologic diseases during a measles outbreak. Vaccination adverse events were reported by parents 30 days following vaccination. Long term effects were evaluated 12 months post vaccination. RESULTS: Twenty-seven children were vaccinated (36 doses given). Half of parents (51.8%) reported no adverse events following immunization. Adverse events included afebrile seizures (6/36), fever alone (5/36) and febrile seizures (5/36). Two children required hospitalization. Quadrivalent measles-containing vaccine combined with varicella was associated with febrile seizures (p = 0.04). No child needed adjustment of the anti-epileptic treatment or exhibited developmental regression. CONCLUSION: Ina series of children with prior severe neurologic disease, the safety-tolerability profile ofvaccines containing a measles vaccine component suggests that vaccination is justified. Main side effect was seizure aggravation in children with known epileptic disease.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Dimopoulou D, Koutsaki M, Giorgi M, et al. Effects of measles-containing vaccination in children with severe underlying neurologic disease. Vaccine. 2020. PMID: 33280857. doi:10.1016/j.vaccine.2020.11.061

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。